Product Approval Information
Proper Name: Alpha-1-Proteinase Inhibitor (Human)
Tradename: Zemaira
Manufacturer: Aventis Behring LLC, License #1281
Package Insert (PDF - 101 KB) - July, 2003
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.
Date: July 8, 2003
Indication: Chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor deficiency and evidence of emphysema
July 8, 2003 Approval Letter
Summary Basis for Approval (PDF - 1.9 MB)